Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Schwarzmüller

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Proteomics|March 29, 2026
Comparison of In-Gel and SP3 Based Sample Preparation Protocols for LC-MS/MS Based ProteomicsLuisa Schwarzmüller, Dario Frey, Piotr Zadora, et al.
Journal of Biotechnology|July 12, 2024
Comparing genome-scale metabolic models of the non-resistant Enterococcus faecalis ATCC 19433 and the multi-resistant Enterococcus faecalis V583Seyed Babak Loghmani, Eric Zitzow, Luisa Schwarzmüller, et al.
Molecular Oncology|June 6, 2026
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer modelLuisa Schwarzmüller, Janina Müller, Efstathios-Iason Vlachavas, et al.
NPJ Breast Cancer|December 2, 2023
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targetsLukas Beumers, Efstathios-Iason Vlachavas, Simone Borgoni, et al.
Blood Advances|November 27, 2019
The ParaHox gene Cdx4 induces acute erythroid leukemia in miceSilvia Thoene, Tamoghna Mandal, Naidu M Vegi, et al.
BMC Biology|January 24, 2025
Selective arm-usage of pre-miR-1307 dysregulates angiogenesis and affects breast cancer aggressivenessOyku Ece Sumer, Korbinian Schelzig, Janine Jung, et al.
Clinical Epigenetics|April 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancerJanina Müller, Emre Sofyali, Luisa Schwarzmüller, et al.
Science Signaling|April 22, 2025
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapseDiana Drago-Garcia, Suvendu Giri, Rishita Chatterjee, et al.
Nature Communications|October 2, 2025
Multicenter evaluation of label-free quantification in human plasma on a high dynamic range benchmark setUte Distler, Han Byul Yoo, Oliver Kardell, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Proteomics|March 29, 2026
Comparison of In-Gel and SP3 Based Sample Preparation Protocols for LC-MS/MS Based ProteomicsLuisa Schwarzmüller, Dario Frey, Piotr Zadora, et al.
Journal of Biotechnology|July 12, 2024
Comparing genome-scale metabolic models of the non-resistant Enterococcus faecalis ATCC 19433 and the multi-resistant Enterococcus faecalis V583Seyed Babak Loghmani, Eric Zitzow, Luisa Schwarzmüller, et al.
Molecular Oncology|June 6, 2026
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer modelLuisa Schwarzmüller, Janina Müller, Efstathios-Iason Vlachavas, et al.
NPJ Breast Cancer|December 2, 2023
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targetsLukas Beumers, Efstathios-Iason Vlachavas, Simone Borgoni, et al.
Blood Advances|November 27, 2019
The ParaHox gene Cdx4 induces acute erythroid leukemia in miceSilvia Thoene, Tamoghna Mandal, Naidu M Vegi, et al.
BMC Biology|January 24, 2025
Selective arm-usage of pre-miR-1307 dysregulates angiogenesis and affects breast cancer aggressivenessOyku Ece Sumer, Korbinian Schelzig, Janine Jung, et al.
Clinical Epigenetics|April 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancerJanina Müller, Emre Sofyali, Luisa Schwarzmüller, et al.
Science Signaling|April 22, 2025
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapseDiana Drago-Garcia, Suvendu Giri, Rishita Chatterjee, et al.
Nature Communications|October 2, 2025
Multicenter evaluation of label-free quantification in human plasma on a high dynamic range benchmark setUte Distler, Han Byul Yoo, Oliver Kardell, et al.
Pageof 1